1. The NSS-2 Bridge is a nerve stimulation device to treat opioid withdrawal symptoms, such as nausea, vomiting and abdominal pain.
2. Mepsevii is an enzyme replacement therapy for patients with Mucopolysaccharidosis VII, an inherited metabolic condition.
3. Hemlibra is a once-weekly injection for patients with hemophilia A who have developed a resistance to other treatments.
4. Abilify MyCite, used to treat schizophrenia, acute bipolar disorder and adult depression, is the first approved drug that can track medication ingestion and alert a patient’s physician or caregiver when it is taken.
5. Sutent may now be used to treat patients who’ve had a kidney surgically removed to lower the risk of cancer recurrence.
More articles on supply chain:
Geisinger, Intermountain among 11 healthcare groups urging CMS to add device identifiers to claims form
Genentech earns FDA approval for hemophilia drug
6 must-reads for supply chain leaders this week
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.